Heart failure is increasing in prevalence in many countries with aging populations.
Fortunately, remarkable scientific advances have been made in the past few years that have …

Importance Prior studies have suggested patients with heart failure (HF) from rural areas
have worse clinical outcomes. Contemporary differences between rural and urban hospitals …

Background Polypharmacy is common among patients with heart failure with reduced
ejection fraction (HFrEF). However, its impact on the use of optimal guideline-directed …

Abstract Purpose of Review Pharmacoequity refers to the goal of ensuring that all patients
have access to high-quality medications, regardless of their race, ethnicity, gender, or other …

Background Patterns and disparities in guideline-directed medical therapy (GDMT) uptake
for heart failure with reduced ejection fraction (HFrEF) across rural vs urban regions are not …

Background The use of recommended heart failure (HF) medications has improved over
time, but opportunities for improvement persist among women and at rural hospitals …

Heart failure (HF) is responsible for substantial morbidity among the estimated 6 million
affected adults in the United States. 1 For HF with reduced ejection fraction (HFrEF), optimal …

Background Despite evidence that guideline-directed medical therapies (GDMTs) improve
outcomes in patients with heart failure (HF) with reduced ejection fraction (HFrEF) …

BACKGROUND: Disparities in guideline-based quality measures likely contribute to
differences in heart failure (HF) outcomes. We evaluated between-and within-hospital …

Background Guideline-directed medical therapy (GDMT) decisions may be less affected by
single patient variables such as blood pressure or kidney function and more by overall risk …